The global
thrombectomy devices market is projected to grow at a CAGR of
6-8% from 2024 to 2029. This growth is primarily driven by an
increasing prevalence of stroke and cardiovascular diseases, demand for
minimally invasive procedures, and technological advancements in thrombectomy
devices. Expansion in emerging markets, combined with an aging population prone
to vascular diseases, is expected to further propel market growth.
The thrombectomy devices market focuses on devices used to
remove clots from blood vessels to restore normal blood flow, critical in
treating stroke and heart attack patients. This market includes diverse
thrombectomy techniques such as aspiration, mechanical, and rheolytic,
providing options for minimally invasive clot retrieval. Innovations like
aspiration catheter systems with improved clot removal efficiency and stent
retriever advancements support detailed, effective vascular treatment across
hospitals and specialized clinics globally.
Download a free sample report now 👉
https://meditechinsights.com/global-thrombectomy-devices-market/request-sample/
Rising Demand for Thrombectomy in Stroke and
Cardiovascular Procedures
The rise in the global burden of stroke and cardiovascular
conditions drives the thrombectomy devices market. Real-time, minimally
invasive thrombectomy procedures provide better outcomes and recovery times.
Cardiovascular diseases accounts for approximately one third of all global
deaths, with ischemic stroke as a leading cause. National initiatives such as
the "Billion Hearts" program in the U.S. and substantial R&D
investments in stroke care underscore the ongoing need for effective treatment
tools like thrombectomy. Technological advancements, such as next-generation
aspiration catheters and stent retrievers, support more precise clot removal,
fueling the market growth.
Technological Advancements to Drive Thrombectomy Devices
Market Growth
Technological advancements are driving the growth of the
thrombectomy devices market, as companies introduce innovative devices that
improve safety, efficiency, and clinical outcomes. For instance, Penumbra Inc.
launched the Lightning Flash system in 2023, integrating intelligent aspiration
technology that uses pressure and flow-based algorithms to detect and remove
large clots, especially for deep vein thrombosis and pulmonary embolism cases.
Inari Medical followed suit in 2023 with the RevCore catheter,
specifically designed for venous in-stent thrombosis, alongside the Triever16
Curve, which enhances precision for both pulmonary embolism and peripheral
thrombectomy treatments. These product launches highlight the industry’s focus
on developing versatile and advanced solutions, fueling adoption across
vascular and neurological applications.
Competitive Landscape Analysis
In the competitive landscape of the thrombectomy devices
market, several prominent players drive innovation and market expansion through
strategic investments, partnerships, and technological advancements. Key
companies include Medtronic; Boston Scientific; Stryker
Corporation; Penumbra Inc.; Edwards Lifesciences; Abbott
Laboratories; Terumo Corporation; AngioDynamics, Inc.; Spectranetics
Corporation; and Inari Medical; among others. These firms focus on
improving device efficacy, expanding product offerings, and forming
partnerships to broaden their portfolios and global reach.
Download a sample report for
in-depth competitive insights
https://meditechinsights.com/global-thrombectomy-devices-market/request-sample/
Market Segmentation
This report by Medi-Tech Insights provides the size of the
global thrombectomy devices market at the regional- and country-level from 2022
to 2029. The report further segments the market based on device type,
application, and end user.
- Market
Size & Forecast (2022-2029), By Device Type, USD Billion
- Mechanical/Fragmentation
Thrombectomy Devices
- Aspiration
Thrombectomy Devices
- Rheolytic/Hydrodynamic
Thrombectomy Devices
- Ultrasound-assisted
Thrombectomy Devices
- Others
- Market
Size & Forecast (2022-2029), By Application, USD Billion
- Neurovascular
Thrombectomy
- Cardiovascular
Thrombectomy
- Peripheral
Thrombectomy
- Market
Size & Forecast (2022-2029), By End User, USD Billion
- Hospitals
and Health Systems
- Ambulatory
Surgical Centers (ASCs)
- Others
- Market
Size & Forecast (2022-2029), By Region, USD Billion
- North
America
- US
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest
of Europe
- Asia
Pacific
- China
- India
- Japan
- Rest
of Asia Pacific
- Latin
America
- Middle
East & Africa
Medi-Tech Insights
is a healthcare-focused business research & insights firm. Our clients
include Fortune 500 companies, blue-chip investors & hyper-growth
start-ups. We have completed 100+ projects in Digital Health, Healthcare IT,
Medical Technology, Medical Devices & Pharma Services in the areas of
market assessments, due diligence, competitive intelligence, market sizing and
forecasting, pricing analysis & go-to-market strategy. Our methodology
includes rigorous secondary research combined with deep-dive interviews with
industry-leading CXO, VPs, and key demand/supply side decision-makers.
Contact:
Ruta Halde
Associate, Medi-Tech Insights
+32 498 86 80 79
info@meditechinsights.com
Comments
Post a Comment